Pregled po CROSBI profilu: Eduard Vrdoljak (CROSBI Profil: 29490, MBZ: 205415)
Pronađeno 258 radova
-
26.Vrdoljak, Eduard; Sullivan, Richard; Lawler, MarkCancer and coronavirus disease 2019; how do we manage cancer optimally through a public health crisis? // European Journal of Cancer, 132 (2020), 98-99 doi:10.1016/j.ejca.2020.04.001 (međunarodna recenzija, pismo uredniku, stručni)
-
27.Omrčen Tomislav, Eterović Davor, Vrdoljak EduardPredictors of resistance to abiraterone acetate or enzalutamide in patients with metastatic castration-resistant prostate cancer in post- docetaxel setting: a single-center cohort study // Anti-cancer drugs, 31 (2020), 7; 742-746 doi:10.1097/CAD.0000000000000945 (međunarodna recenzija, članak, znanstveni)
-
28.Omrčen Tomislav, Katić Andrija, Tomić Snježana, Eterović Davor, Vrdoljak EduardPredictors of outcome in elderly patients with metastatic colorectal cancer: the final results of a prospective phase II study of bevacizumab in combination with capecitabine as first-line treatment // Anti-cancer drugs, 31 (2020), 5; 518-522 (međunarodna recenzija, članak, znanstveni)
-
29.Čerina D., Katić A., Paparella Karaman A., Hrepić D., Vrdoljak E.Molecular profiling frequency of metastatic colorectal carcinoma and it's impact on the outcomes: a single institution status report in 2017. // 13. Hrvatski onkološki kongres
Poreč, Hrvatska, 2020. 109, 3 (poster, sažetak, stručni) -
30.Pancirov M., Hrepić D., Vrdoljak E.Hepatotoxicity profiles of biosimilars v. generic antiher2 therapy in everyday clinical practice - observational study at the department of oncology and radiotherapy // 13. hrvatski onkološki kongres (HOK)
Poreč, Hrvatska, 2020. 110, 3 (poster, sažetak, znanstveni) -
31.Pancirov, Marija; Majić, Ana; Tomić, Snježana; Dolić, Krešimir; Krnić, Mladen; Petrić Miše, Branka; Vrdoljak, EduardFirst experience of alpelisib treatment of HR+ HER2- metastatic breast carcinoma in Croatia // Libri Oncologici 48(Suppl.1). Poster presentation / Vrdoljak, Danko Velimir (ur.).
Zagreb, 2020. str. 121-121 (poster, međunarodna recenzija, sažetak, stručni) -
32.Majić, Ana; Petrić Miše, Branka; Vrdoljak, EduardBRAF mutant metastatic melanoma: A case report // 13th Croatian oncology congress.Libri Oncologici. 2020 ; 48(Suppl 1) / Vrdoljak, Danko Velimir (ur.).
Zagreb, 2020. str. 53-53 (predavanje, međunarodna recenzija, sažetak, stručni) -
33.Ban, Marija; Petrić Miše, Branka; Vrdoljak EduardEarly HER2-Positive Breast Cancer: Current Treatment and Novel Approaches // Breast care, 15 (2020), 6; 560-568 doi:10.1159/000511883 (međunarodna recenzija, pregledni rad, znanstveni)
-
34.Majić, Ana; Petrić Miše, Branka; Matković, Višnja; Belac Lovasić, Ingrid; Katić, Kristina; Canjko, Ivana; Frobe, Ana; Bajić, Željko; Vrdoljak, EduardOlaparib outcomes in patients with BRCA 1-2 mutated, platinum-sensitive, recurrent ovarian cancer in Croatia: A retrospective noninterventional study // Journal of oncology, 2020 (2020), 64223936, 6 doi:10.1155/2020/6423936 (međunarodna recenzija, članak, znanstveni)
-
35.Mamić, Bisera; Boraska Jelavić, Tihana; Podrug, Mario; Ban, Marija; Vrdoljak, EduardNeoadjuvantno liječenje raka dojke u KBC Split // 12. hrvatski onkološki kongres : s međunarodnim sudjelovanjem : 04-07.04.2019, Poreč : knjiga sažetaka / Vrdoljak, Eduard (ur.).
Zagreb: Hrvatsko onkološko društvo HLZ-a, 2019. (predavanje, podatak o recenziji nije dostupan, ostalo, znanstveni) -
36.(AROME ; ESO) Todorović, Vladimir; Aapro, Matti; Pavlidis, Nicholas; Arsovski, Oliver; Belkacemi, Yazid; Babović, Nada; Bidard, Francois Clement; Bourhafour, Mouna; Bešlija, Semir; Boussen, Hamouda et al.AROME-ESO Oncology Consensus Conference: access to cancer care innovations in countries with limited resources. Association of Radiotherapy and Oncology of the Mediterranean Area (AROME-Paris) and European School of Oncology (ESO - Milan) // JBUON, 24 (2019), 5; 2180-2197 (međunarodna recenzija, članak, znanstveni)
-
37.Vrdoljak, Eduard; Bodoky, Gyorgy; Jassem, Jacek; Popescu, Razvan; Pirker, Robert; Čufer, Tanja; Bešlija, Semir; Eniu, Alexandru; Todorović, Vladimir; Kopečková, Katerina et al.Expenditures on Oncology Drugs and Cancer Mortality- to-Incidence Ratio in Central and Eastern Europe // The Oncologist, 24 (2019), 1; e30-e37 doi:10.1634/theoncologist.2018-0093 (međunarodna recenzija, članak, znanstveni)
-
38.Omrčen Tomislav, Eterović Davor, Vrdoljak EduardPredictors of resistance to abiraterone acetate (AA) or enzalutamide (ENZ) in patients with metastatic castration-resistant prostate cancer (mCRPC) in the post-docetaxel setting // 11th European Multidisciplinary Congress on Urological Cancers: Implementing multidisciplinary strategies in genito-urinary cancers. European Urology Supplements. 2019 ; 18(11)
Beč, Austrija: Elsevier, 2019. str. 3491-3492 doi:10.1016/ S1569-9056(19)34647-0 (poster, međunarodna recenzija, prošireni sažetak, stručni) -
39.Omrčen Tomislav, Katic Andrija, Tomić Snježana, Eterović Davor, Vrdoljak EduardDoes metastatic colorectal cancer in elderly patients have specific features: the final results of prospective phase Iistudy of bevacizumab in combination with capecitabin // ESMO 21st World Congress on Gastrointestinal Cancer. Annals of Oncology. 2019 ; 30 (Supplement 4)
Barcelona, Španjolska, 2019. str. 65-65 doi:10.1093./annonc/mdz155.236 (poster, međunarodna recenzija, sažetak, stručni) -
40.Omrčen Tomislav, Puljić Ćuk Ana, Hrepić Darijo, Vrdoljak EduardTrifluridin-tipiracil u liječenju bolesnika s metastatskim rakom debelog crijeva u Klinici za onkologiju i radioterapiju u Splitu: retrospektivna analiza // Knjiga sažetaka
Poreč, Hrvatska, 2019. str. 78-78 (poster, domaća recenzija, sažetak, stručni) -
41.(AROME ; ESO) Todorović, Vladimir; Aapro, Matti; Pavlidis, Nicholas; Arsovski, Oliver; Belkacemi, Yazid; Babović, Nada; Bidard, François Clément; Bourhafour, Mouna; Bešlija, Semir; Boussen, Hamouda et al.AROME-ESO Oncology Consensus Conference: access to cancer care innovations in countries with limited resources. Association of Radiotherapy and Oncology of the Mediterranean Area (AROME–Paris) and European School of Oncology (ESO – Milan) // JBUON, 24 (2019), 5; 2180-2197 (međunarodna recenzija, članak, znanstveni)
-
42.Majić, Ana; Mamić, Bisera; Buljubašić, Matea; Jazvo, Marija; Petrić Miše, Branka; Vrdoljak, EduardPredoperativna dijagnostička obrada pacijentica s rakom dojke prezentiranih na Multidisciplinarnom timu (MDT) Klinike za onkologiju i radioterapiju KBC-a Split u 2017. godini // Zbornik sažetaka
Poreč, Hrvatska, 2019. str. 72-72 (poster, domaća recenzija, sažetak, stručni) -
43.Petrić Miše, Branka; Katić, Andrija; Majić, Ana; Vrdoljak, EduardOlaparib u terapiji održavanja kod recidiva platina-osjetljivog karcinoma jajnika - iskustva Klinike za onkologiju i radioterapiju KBC Split // Zbornik sažetaka
Poreč, Hrvatska, 2019. str. 83-83 (poster, domaća recenzija, sažetak, stručni) -
44.Vrdoljak, Josip; Boban, Toni; Petrić Miše, Branka; Boraska Jelavić, Tihana; Bajić, Željko; Tomić, Snježana; Vrdoljak, EduardEfficacy and safety of TC dose-dense chemotherapy as first-line treatment of epithelial ovarian cancer: a single-institution retrospective cohort study // Japanese journal of clinical oncology, 49 (2019), 4; 347-353 doi:10.1093/jjco/hyz011 (međunarodna recenzija, članak, znanstveni)
-
45.Ban, Marija; Strikić, Ante; Petrić Miše, Branka; Vrdoljak, EduardUloga inhibitora CDK4/6 u liječenju hormonski ovisnoga metastatskog raka dojke negativnog na HER2 // Liječnički vjesnik : glasilo Hrvatskoga liječničkog zbora, 141 (2019), 1-2; 33-39 doi:10.26800/lv-141-1-2-6 (međunarodna recenzija, članak, znanstveni)
-
46.Omrčen, Tomislav; Boraska Jelavić, Tihana; Šitum, Marijan; Vilović, Katarina; Dolić, Krešimir; Zahirović, Dag; Pavlović Ružić, Ira; Krpina, Kristian; Jazvić, Marijana; Ružić, Boris et al.Smjernice za dijagnosticiranje, liječenje i praćenje bolesnika s rakom bubrega // Liječnički vjesnik : glasilo Hrvatskoga liječničkog zbora, 141 (2019), 11-12; 336-342 doi:10.26800/LV-141-11-12-43 (međunarodna recenzija, pregledni rad, znanstveni)
-
47.Kim, Tae Won; …; Vrdoljak, EduardFinal Analysis of Outcomes and RAS/BRAF Status in a Randomized Phase 3 Study of Panitumumab and Best Supportive Care in Chemorefractory Wild Type KRAS Metastatic Colorectal Cancer // Clinical Colorectal Cancer, 17 (2018), 3; 206-214 doi:10.1016/j.clcc.2018.03.008 (međunarodna recenzija, članak, znanstveni)
-
48.Pivot, X.; Poole, C.; Martín, M.; Gligorov, J.; Barrios, C.H.; Vrdoljak, Eduard; Zambetti, M.; Woodward, N.; Ten Tije, A.J.; Lindegger, N. et al.The open-label, multinational, multicenter, Phase IIIB umbrella study of subcutaneous trastuzumab with or without chemotherapy or pertuzumab in patients (pts) with HER2-positive early breast cancer (EBC) or metastatic breast cancer (MBC): Pooled analysis of safety data from the UmbHER1 program // EUROPEAN JOURNAL OF CANCER
Barcelona, Španjolska: Elsevier BV, 2018. str. S105-S106 doi:10.1016/s0959-8049(18)30542-2 (poster, međunarodna recenzija, sažetak, stručni) -
49.Vrdoljak, Josip; Boban, T.; Petrić Miše, Branka; Boraska Jelavić, Tihana; Bajić, Z.; Tomić, Snježana; Vrdoljak, EduardEFFICACY AND SAFETY OF TC DOSE-DENSE CHEMOTHERAPY IN FIRST-LINE TREATMENT OF ADVANCED OVARIAN CANCER; A RETROSPECTIVE COHORT STUDY IN THE SINGLE INSTITUTION // INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
Kyoto, Japan, 2018. str. 866-866 (poster, međunarodna recenzija, sažetak, stručni) -
50.Begum, Mursheda; Lewison, Grant; Jassem, Jacek; Mixich, Vlad; Cufer, Tanja; Nurgozhin, Talgat; Shabalkin, Pavel; Kutluk, Tezer; Voko, Zoltan; Radosavljevic, Davorin et al.Mapping cancer research across Central and Eastern Europe, the Russian Federation and Central Asia: Implications for future national cancer control planning // European journal of cancer, 104 (2018), 127-136 doi:10.1016/j.ejca.2018.08.024 (međunarodna recenzija, članak, znanstveni)
